|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CISTRON BIOTECHNOLOGY INC, 10-K, 2000-09-07 |
Next: CISTRON BIOTECHNOLOGY INC, 10-K, EX-2.1A, 2000-09-07 |
<TABLE> <S> <C>
<S> <C>
<ARTICLE> 5
<LEGEND>
This Schedule contains summary financial information taken from the
balance sheet as of June 30, 2000 and the statement of operations for
the twelve-month period ended June 30, 2000, and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-END> JUN-30-2000
<CASH> 9,095,618
<SECURITIES> 0
<RECEIVABLES> 1,211,300
<ALLOWANCES> 230,000
<INVENTORY> 0
<CURRENT-ASSETS> 10,076,918
<PP&E> 0
<DEPRECIATION> 0
<TOTAL-ASSETS> 10,076,918
<CURRENT-LIABILITIES> 561,782
<BONDS> 0
0
0
<COMMON> 303,668
<OTHER-SE> 9,211,468
<TOTAL-LIABILITY-AND-EQUITY> 10,076,918
<SALES> 52,690
<TOTAL-REVENUES> 851,814
<CGS> 142,417
<TOTAL-COSTS> 142,417
<OTHER-EXPENSES> 1,557,472
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 399,128
<INCOME-PRETAX> (848,076)
<INCOME-TAX> 19,950
<INCOME-CONTINUING> (828,126)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (828,126)
<EPS-BASIC> (0.04)
<EPS-DILUTED> (0.04)
</TABLE>
|
|